Related Experiment Video

Updated: Nov 14, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.6K

In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic

Hye-Kyung Cho1, Melissa J Karau1, Kerryl E Greenwood-Quaintance1

  • 1Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN.

Antimicrobial Agents and Chemotherapy
|March 9, 2021
PubMed

Insights

Treating MRSA periprosthetic joint infection is difficult due to biofilms and variable vancomycin effectiveness. New strategies are needed to improve outcomes for these challenging infections.

Area of Science:

  • Orthopedic surgery
  • Infectious diseases
  • Microbiology

Background:

  • Periprosthetic joint infection (PJI) caused by Methicillin-resistant Staphylococcus aureus (MRSA) presents significant therapeutic challenges.
  • Biofilm formation by MRSA contributes to treatment resistance and recurrence.
  • Limited efficacy of vancomycin, a common antibiotic, further complicates MRSA PJI management.

Discussion:

  • The complex nature of MRSA PJI necessitates exploring alternative or adjunctive therapeutic approaches.
  • Understanding the mechanisms of vancomycin activity and resistance in the context of biofilms is crucial.
  • Investigating novel antimicrobial agents or strategies to eradicate MRSA biofilms is warranted.

Key Insights:

  • MRSA PJI is a complex orthopedic infection characterized by challenging biofilm formation.
  • Vancomycin activity against MRSA in PJI can be inconsistent, impacting treatment success.
  • Effective management requires addressing both bacterial load and biofilm integrity.

Outlook:

  • Future research should focus on developing innovative treatments targeting MRSA biofilms in PJI.
  • Exploring combination therapies or novel drug delivery systems may enhance vancomycin efficacy.
  • Improving diagnostic and therapeutic paradigms for MRSA PJI is essential for better patient outcomes.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.6K
Development and Assessment of Intracellular Infection Models for Staphylococcus aureus08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

909

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
735
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.3K